Aclipse Therapeutics is a forward-thinking biopharmaceutical firm that specializes in the development of innovative and highly unique medications to tackle diseases with substantial unmet medical needs. The company's approach involves mitigating clinical development risk by integrating a fresh and targetable comprehension of disease pathways with a unique version of an existing medication that thwarts these pathways. This approach enables the company to expand on existing preclinical and clinical data while establishing a substantial patent barrier to entry.
Aclipse Therapeutics
Headquarters
United States of America